Results 241 to 250 of about 51,792 (280)
Some of the next articles are maybe not open access.
Dental Clinics of North America, 2011
Hemostasis is an integral and very important aspect of surgical practice. As a rule, most bleeding from dental surgery can be controlled by pressure. When the application of pressure does not yield satisfactory results, or where more effective hemostasis is required, hemostatic agents are used.
Orrett E, Ogle +2 more
openaire +2 more sources
Hemostasis is an integral and very important aspect of surgical practice. As a rule, most bleeding from dental surgery can be controlled by pressure. When the application of pressure does not yield satisfactory results, or where more effective hemostasis is required, hemostatic agents are used.
Orrett E, Ogle +2 more
openaire +2 more sources
Hemostatic changes in vasculitides
Thrombosis Research, 2009The systemic vasculitides are an heterogeneous group of rare diseases characterized by inflammation and fibrinoid necrosis of blood vessel walls. Today it is well known that the inflammatory process characterizing vasculitides activates coagulation factors, inhibits anticoagulant factors, inhibits fibrinolytic processes, increases platelet activity and
TRIFILETTI A +3 more
openaire +3 more sources
Cancer Biotherapy and Radiopharmaceuticals, 2000
We investigated effects of hemostatics used during operations for digestive organ on cancer cells present in the peritoneal cavity using BALB/c mice inoculated with Meth A tumor cells (fibrosarcoma) intraperitoneally (i.p.) and C3H/He mice inoculated ...
N. Kubota, T. Kojima, T. Naruse
semanticscholar +1 more source
We investigated effects of hemostatics used during operations for digestive organ on cancer cells present in the peritoneal cavity using BALB/c mice inoculated with Meth A tumor cells (fibrosarcoma) intraperitoneally (i.p.) and C3H/He mice inoculated ...
N. Kubota, T. Kojima, T. Naruse
semanticscholar +1 more source
The Hemostatic System and Malignancy
Clinical Lymphoma and Myeloma, 2008There is an intimate relationship between the processes involved in malignancy and hemostasis. The mechanisms by which malignancy promotes thrombosis are reviewed herein. Emphasis, however, is placed upon the potential mechanisms by which the hemostatic system modulates malignant potential of tumors.
Adcock DM +4 more
openaire +4 more sources
Fibrinogen as a Hemostatic Agent
Seminars in Thrombosis and Hemostasis, 2012Coagulation factor I (fibrinogen) plays an essential role in the hemostatic system by bridging activated platelets and being the key substrate for thrombin in establishing a consolidating fibrin network. Fibrinogen is synthesized in the liver and the plasma concentration is 1 to 5-4.0 g/L.
Jonathan H. Foley +6 more
openaire +3 more sources
Study on hemostatic mechanism of fully soluble hemostatic fiber
Blood Coagulation & Fibrinolysis, 2007Fully soluble hemostatic fiber (FHF) is made from cotton yarn through a series of chemical reactions with NaOH and chloroacetic acid. The major component of FHF is carboxymethylcellulose. FHF is a kind of biodegradation macromolecule material that can disassociate into a low-molecular-weight compound or a simple substance by hydrolytic and enzymatic ...
Jihong Yao +3 more
openaire +3 more sources
Graphene-Montmorillonite Composite Sponge for Safe and Effective Hemostasis.
ACS Applied Materials and Interfaces, 2016Montmorillonite (MMT) is considered to be the most effective hemostat among natural phyllosilicates. However, there is a barrier against using MMT for the commercial hemostatics because the invaded MMT powders might cause thrombosis in vessel. Until now,
Guofeng Li +7 more
semanticscholar +1 more source
Seminars in Thrombosis and Hemostasis, 2015
The mainstay of treatment of inherited coagulation disorders is based on the infusion of the deficient clotting factor, when available. Significant advances have been made over the past two decades in the production and availability of factor replacement products.
Franchini, Massimo +2 more
openaire +4 more sources
The mainstay of treatment of inherited coagulation disorders is based on the infusion of the deficient clotting factor, when available. Significant advances have been made over the past two decades in the production and availability of factor replacement products.
Franchini, Massimo +2 more
openaire +4 more sources
Anticoagulants, Antithrombotics, and Hemostatics
, 2003Maintenance of proper blood flow is a complex and highly regulated physiological process, with multiple complementary and opposing mechanisms of control.
G. Bisacchi
semanticscholar +1 more source
Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat
Critical Reviews in Oncology/Hematology, 2012Sustaining hemostasis in clinical hemorrhages is a challenging task and requires extensive effort to stabilize medically hard-to-treat traumatic injuries. Several hemostatic agents are preferred to control external and internal bleedings, yet commercially available products are not sufficiently effective or fast-acting to achieve hemostasis in extreme ...
Berat Z. Haznedaroglu +3 more
openaire +3 more sources